Ann: 2024 Half Year Investor Presentation, page-110

Think we would be well north of .30 something given company stands a good chance of getting market share in women's health the States . Without going into detail of what we've got to offer but enough to suggest there should be a lot more buying interest in this stock than there is presently but around $7 ? a share think that alone puts paid to stock moving forward to where we want it to be until we show real growth / net earnings , solid evidence such as full year net earnings . More than likely be something like .60 if we had not consolidated . Think concern retail investors might have in regards buying into Mayne apart from paying around $7 a share ( for a speculative stock) might be what security is there to borrow against knowing they're investing in a loss making company and for how much longer .